GO
Loading...

Enter multiple symbols separated by commas

Mark Koba

Mark Koba
Senior Editor, CNBC

Mark Koba is a senior editor at CNBC.com. Topics for his feature story writing include the business of politics, health care, employment and the economy.

Before working at CNBC.com, he spent 11 years at Bloomberg LP, where among various duties, he was program producer for the award-winning "Bloomberg Small Business" television show.

Koba's background includes a decade of news writing and show producing at CNN, E! Entertainment Television, ABC's "World News Now," "Good Morning America" and CBS' "This Morning."

Follow Mark Koba on Twitter @MarkKobaCNBC.

More

  • Celeb Cromwell--Turning Into Stock Trading Machine!
    By: Mark Koba
    Tuesday, 27 Mar 2007 | 10:31 AM ET

    Most of our celebs had a slow day Monday, but James Cromwell "has been a machine" as someone said. Not only is he buying stocks, he's putting those bonus bucks to work--something the other celebs--and you non-celebs should be using to your advantage. Willie Garson used them to put Johnny Bench back in last place.

  • BSTE Stock Makes "Healthy" Run With Leaders
    By: Mark Koba
    Tuesday, 27 Mar 2007 | 9:52 AM ET

    Hey folks. Here's the best performing trades by % gain from Friday's close to Monday's close: Biosite--If you bought on Friday at $55.38 and held/sold on Monday with a close of $83.80, the contestant gained 51.32% on the trade (9 out of the 10 current weekly leaders as of Monday's close bought BSTE on Friday).

  • Top Name Repeats on Leaderboard
    By: Mark Koba
    Tuesday, 27 Mar 2007 | 9:28 AM ET

    Good morning. Here are the latest names and numbers from Monday's action. Deborah Taft continues in the lead with a portfolio value of $2,216,726.30. Her biggest portfolio gains continue to be in the ever popular Fremont General which she sold out of completely on 3/21. She made $23,062.62 or 1.05% on buying and selling 164,733 shares of Elan Pharma.